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choosing this mono-energy, it is possible to achieve MAR in patients 
with hip prostheses. This approach is simple and easy to 
implement.The goal of this study is to assess the MAR capacity of 
DECT in the context of LDR seed implants. More specifically, we aim 
to ascertain whether the use of DECT can yield dose calculations 
whose accuracy is not marred by metal artefacts. 
Materials and Methods: DECT imaging at 100 kVp and 140 kVp was 
performed on an ultrasound phantom designed for prostate implants 
containing inert LDR brachytherapy seeds. The magnitude of artefacts 
was evaluated as a function of mono-energetic attenuation maps by 
comparing the standard deviation (σ) in a region of interest (ROI) 
containing artefacts and one free of artefacts. The ROIs exclude the 
high signal from the seeds themselves. Additionally, the same analysis 
was performed on the density map obtained from the standard DECT 
ρ-Z decomposition which provides a density map directly. 
Results: 
 Figure 1 
Figure 1A shows the 140 kVp HU (displayed range=[-100 to 200 HU]) 
with streaking artefacts. Figure 1B shows the density map from ρ-Z 
decomposition (displayed range=[0.9 to 1.2 g/cc]). Comparing the 
140kVp HU image and the density map confirms that DECT provides 
MAR for seed implants. The magnitude of the metal artefacts in mono 
energetic images was found to decrease with increasing keV from 70 
keV to 150 keV, as can be seen in figure 1C. The ratio of σartefact/σno-
artefact(E) is plotted for the ROIs seen in Figure 1A. The σartefact/σno-
artefact(E) from the density map is plotted as a horizontal line. Our 
results suggest that the MAR from the density map from ρ-Z 
decomposition is better than the mono-energetic images, or 
alternately that the density map corresponds to the best high keV 
mono-energetic image. The increased noise in the density map can be 
reduced by optimizing the separation of the high and low kVp spectra. 
Conclusions: Mono-energetic images from DECT with a high keV 
provide MAR in seed implants. The MAR is equivalent to that obtained 
from the density map. The technique is promising and the impact on 
dose calculation accuracy will be investigated using Monte Carlo 
techniques. 
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Purpose/Objective: Brachytherapy provides one of the best cure rates 
for the treatment of prostate cancer but is highly skill dependent. An 
interactive electromagnetic needle navigation system was developed 
to reduce uncertainty in the implant procedure and expand the 
capabilities of patient-specific implant techniques. 
Materials and Methods: A gelatin phantom was placed inside the work 
space of a magnet field generator device which tracks the 3D 
locations of small EM-signal-producing coils. These coils were placed 
on the end of an endorectal ultrasound probe, upon the probe 
stepper, and embedded within the wall of a 16 gauge brachytherapy 
needle. The needle allows passage of a standard prostate 
brachytherapy seed. These coils provide real-time patient, probe, and 
needle coordinates. Additionally,the system has a mechanism by 
which the 3D coordinate and time information provided by the EM 
tracking device at the moment the seed is deposited in tissue can be 
automatically recorded. 
Experiments were performed to qualitatively determine the usability 
of the navigation system, as well as to measure the accuracy of the 
automated seed localization. Multiple seed implants were performed 
upon a phantom and the automated EM coordinates were compared to 
the‘true’ locations, as determined by a CT scan. These two coordinate 
systems were co-registered using a CT marker placed on the side of 
the phantom, for which the location was determined using the EM 
tracked needle by placing the tip upon opposite sides of the marker 
and averaging the locations’ coordinates. The precision of the seed 
localization is determined by evaluating the differences in relative 
seed locations within each coordinate system.  
Results: The system hardware, interface, and workflow validation 
experiments were implemented to demonstrate that EM needle 
tracking can guide implantation of seeds with minimal user expertise. 
Trials with the EM system have shown,qualitatively, an increase in 
usability and ease of needle navigation. Preliminary results also 
indicate the EM tracking seed localization is precise to 2.7 mm (1 
sigma). 
Conclusions: A system has been developed to assist the placement of 
radioactive seeds for the treatment of prostate cancer and reduce the 
dependence on physician skill-level, as well as facilitate skew-line 
needle arrangements and allow for improved mid-procedure re-
optimization based on seed deposition errors. The system will help 
reduce the number of attempts to bring a needle to the correct seed 
dropping location as well as facilitate the use of alternative needle 
pattern for organ sparing. Additionally, automated seed dropping 
detection will allow the system and user to know immediately the 
seed location and thereby adjust accordingly. Clinical implementation 
will be needed to determine the extent of increased precision and 
reduced trauma. 
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Purpose/Objective: We have previously shown that a flat panel 
imager can be used for source position localisation in HDR 
brachytherapy. Analysis of the EPID image distribution can be used to 
determine the source position relative to the EPID, but needed to be 
validated independently. Here we describe a method for the 
independent validation of source position coordinates determined in 
the two orthogonal directions parallel to the imager, using a novel 
projection technique combined with HDR source radiation subtraction. 
Materials and Methods: An a-Si EPID (IAS11-19, Varian Medical 
Systems, Palo Alto, CA, USA), removed from a linear accelerator, was 
positioned in contact with a rectangular solid water phantom, which 
included a ball-bearing array, placed against the surface of the 
imager. Brachytherapy catheters were inserted into grooves cut into a 
phantom slab at a distance of 50 mm from the imager surface. A 
mobile x-ray unit was set up at a relatively large distance (1500 mm) 
from the imager. Radio-opaque x-ray source position markers were 
inserted into the catheters and a projection image acquired using the 
external x-ray source and the EPID. A marker was removed and the 
Ir192 brachytherapy source was driven to 5 programmed dwell 
positions, at 10 mm steps, corresponding to the expected x-ray 
marker positions. At each dwell position two images were acquired: 
the first capturing only the radiation emitted by the Ir192 source, 
while the second image acquired also contained an exposure from the 
external x-ray system. Using image subtraction, the position of the 
projection of the physical Ir192 source could be determined and 
correlated with the marker projections (See Figure 1). To account for 
beam divergence effects, the distance of each projection from the 
central axis (CAX) of the external x-ray beam was determined. A 
stereotactic angiographic localisation frame was used as a set of 
known orthogonal pairs of radio-opaque markers, with the CAX 
determined by co-location of the perpendicular pair in the image.  
Results: The centroid coordinates of marker and source projections 
were derived and used to calculate object locations via geometric 
back-projection. Marker locations and the HDR source itself, identified 
using the subtraction method described here, were determined to 
within ± 0.4 mm (± half of the pixel size) at each programmed dwell 
position. Derived source positions matched the marker positions. 
 
S72  2nd ESTRO Forum 2013	
  
Conclusions: The subtraction method described here validates the x-
ray markers as an accurate surrogate for the HDR brachytherapy 
source position. These markers were then appropriate references for 
validation of the algorithm used to determine source position in a two 
dimensional plane parallel to the imaging panel, as derived using an 
EPID based delivery validation system described elsewhere at this 
meeting. EPID measurements of source position were confirmed to be 
accurate within ± 1 mm at source-detector distances up to 200 mm. 
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Purpose/Objective: Prostate cancer patients treated with 
neoadjuvant androgen ablation experience less radiation-induced 
intestinal toxicity. This can be due to the size reduction of bulky 
prostatic tumours and optimization of the target volume. The aim of 
this study was to evaluate if leuprorelin exerts itself a protective 
effect on irradiated bowel. 
Materials and Methods: C57BL/6J mice underwent 12Gy total body 
irradiation (TBI), with or without a monthly i.p. injection of 
leuprorelin (enantone®, 0.054 mg/Kg), started three months before 
TBI. Mice were sacrificed 24 or 72h after TBI and small bowel 
(jejunum, ileum) segments were collected for histological and 
molecular analysis. 
Microcolony survival assay was also performed, to evaluate radiation-
induced damage on crypts and the potential protective effect of 
leuprorelin. Radioprotection was correlated with crypt regeneration; 
crypts containing at least 10 viable cells were considered regenerating 
crypts.  
Results: At hematoxylin eosin staining, untreated controls showed 
normal jejunal wall features,with long villi and well developed tubular 
glands. Irradiation caused a time-dependent reduction of the tubular 
glands and occurrence of a marked inflammatory infiltrate. euprorelin 
pre-treatment appeared to blunt the radiation-induced changes: the 
columnar epithelium mostly showed normal features, with continuous 
striated border and intercalated goblet cells; the inflammatory 
infiltrate in the mucosal/submucosal stroma was markedly reduced in 
comparison with the irradiated mice. 
Real-Time RT-PCR analysis showed that leuprorelin significantly 
decreased radiation-induced collagen type I and type III, TGFbeta, 
Mmp2, Mmp13 and p53 gene expression in the jejunum of treated 
mice. 
Leuprorelin pre-treatment was also able to inhibit TGFbeta and p-
NFkB protein expression induced by irradiation in the jejunum, as 
revealed by western blot analysis. 
Pre-irradiation administration of leuprorelin significantly increased 
the number of regenerating crypts in the jejunum, as compared to 
mice undergone irradiation alone.  
Conclusions: Pretreatment with leuprorelin exerts a protective effect 
against radiation-induced intestinal injury in mice. These findings 
confirm clinical observations in irradiated prostate cancer patients 
and suggest that prostate size reduction is not the only mechanism at 
the basis of better intestinal tolerance after neoadjuvant androgen 
ablation. More investigations are needed to establish a possible way of 
action for the reported effect of leuprorelin on irradiated intestinal 
mucosa  
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Purpose/Objective: The introduction of flattening filter free (FFF) 
photon beams to deliver higher instantaneous dose rates and 
shortened overall treatment times, re-introduced controversy about 
the biological consequences of these high dose rates. We hypothesize 
that high dose rate irradiation will decrease cell survival in normal 
and cancer cell lines and even more in cancer cells deficient for 
homologous recombination. Additionally, we hypothesize that removal 
of the flattening filter will result in an enhanced relative biological 
effectiveness (RBE), independently of the dose rate. 
Materials and Methods: Human breast adenocarcinoma (MCF7), 
colorectal adenocarcinoma (HCT116 and DLD1), glioblastoma (U373 
and U87) and non small cell lung adenocarcinoma (A549) cells were 
irradiated in the range 0 - 10 Gy. Additionally, DNA repair deficient 
HCT116 (DNA-PKcs-/-, NHEJ deficient) or DLD1 (BRCA2-/-, HR 
deficient) and normal breast (MCF10A) and lung bronchial (NL20) 
epithelial cell lines were exposed to similar dose schedules. To 
investigate the effect of high dose rate irradiation, clonogenic survival 
was assessed after exposing cells to 4 or 24 Gy/min FFF using a Varian 
TrueBeam accelerator (10 MV). Additionally, to investigate the effect 
of flattening filter removal on cell survival, cells were exposed to 4 
Gy/min with or without flattening filter. RBE estimations were 
performed comparing the different photon spectra of FF and FFF 
beams. 
Results: Cell survival in tumor or normal tissue cell lines was not 
influenced by high dose rate irradiation. The survival curves for A549 
non small cell lung cancer cells are shown as an example. Although 
DNA repair deficient cell lines showed an increased radiosensitivity, 
high dose rate irradiation did not influence survival. Furthermore, RBE 
was not significantly different from unity in any of the cell lines 
between FFF and conventional flattened beams. 
 
 
Conclusions: High dose rate irradiation did not affect long term cell 
survival and DNA repair for human cancer and normal cell lines of 
different origin. These results suggest that high dose rate does not 
